A child with pericardial effusion and cardiac tamponade due to previously unrecognized hypothyroidism

Srinath Sanda1, Ron S Newfield

  • 1Division of Pediatric Endocrinology, University of Washington School of Medicine, Seattle, WA, USA. ssanda@benaroyaresearch.org

Insights

Undiagnosed hypothyroidism can lead to cardiac tamponade in children. Screening for hypothyroidism is crucial in pediatric patients with unexplained pericardial effusions to prevent this serious complication.

Area of Science:

  • Pediatric Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Hypothyroidism, a condition of insufficient thyroid hormone production, can have diverse clinical manifestations.
  • Pericardial effusion, the accumulation of fluid around the heart, can lead to cardiac tamponade, a life-threatening condition.
  • Early recognition and management of hypothyroidism are vital to prevent severe cardiovascular complications.

Observation:

  • A 12-year-old Hispanic female presented with early cardiac tamponade.
  • The cardiac tamponade was attributed to pericardial effusion.
  • The patient had previously unrecognized hypothyroidism as the underlying cause.

Findings:

  • The case highlights a rare but serious presentation of hypothyroidism in a pediatric patient.
  • Unexplained pericardial effusions in children may be a sign of underlying hypothyroidism.
  • Cardiac tamponade can develop insidiously in the context of undiagnosed hypothyroidism.

Implications:

  • Pediatric patients presenting with unexplained pericardial effusions warrant screening for hypothyroidism.
  • Close monitoring for the development of cardiac tamponade is essential in pediatric patients diagnosed with hypothyroidism.
  • This case underscores the importance of considering endocrine disorders in the differential diagnosis of pediatric cardiovascular emergencies.

Related Concept Videos

Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...